Effects of 1-beta-D-arabinofuranosylcytosine on chromosomes, depending upon the cell cycle stage at the time of exposure.
1-beta-D-Arabinofuranosyl cytosine (ara-C) is a clinically important cytotoxic drug which is a potent inhibitor of DNA but which has a minimal effect on other cellular processes. The cytotoxic action of ara-C on mammalian cells has been suggested to be due to the chromosome aberrations induced by this compound. Using a marsupial cell line (JU56), the cells of which contain only 9 readily identified chromosomes, the different types of chromosome aberrations induced by a pulse of ara-C have been quantified, and the cell cycle dependence of the damage has been assessed. It was found that, for cells exposed in G2, both chromatid-type and chromosome-type lesions were produced. The frequency of these lesions was reduced by a chase of deoxycytidine, and there was some evidence that the initial lesions are gaps which may later be converted to true breaks. In early G2 and late S cells, lesions were produced chiefly at one chromosome locations; this location was not specifically late-replicating. At all stages of S, lesions were chiefly chromatid-type, and some exchanges occurred. The level of damage in S cells was not influenced by a deoxycytidine chase. There was negligible damage in cells exposed in G1. It is suggested that the reason previous investigators have obtained very different cell cycle dependence of chromosome damage is that the delaying effects of ara-C on cell cycle progression was not taken into account.
D000818:Animals; D002453:Cell Cycle; D002460:Cell Line; D002842:Chromatids / Q000648:ultrastructure; D002869:Chromosome Aberrations; D002875:Chromosomes / Q000187:drug effects* / Q000528:radiation effects / Q000648:ultrastructure; D003561:Cytarabine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D007614:Macropodidae; D014965:X-Rays
D003561:Cytarabine